Literature DB >> 20886317

Profile of children with migraine.

Mustafa Aydin1, Nimet Kabakus, Senol Bozdag, Sabahattin Ertugrul.   

Abstract

OBJECTIVE: To assess the clinical characteristics of patients with migraine.
METHODS: The medical records of 76 patients diagnosed with migraine were reviewed using the ICHD-II 2004 diagnosis criteria. The patients were classified into three age groups: 3-6 yr olds (group I), 7-12 yr olds (group II), and 13-17 yr olds (group III).
RESULTS: Migraine was the most common cause of headache in the patients of present pediatric neurology outpatient clinic (57.1%, 76/133). The mean age of patients was 11.08 ± 3.27 (3.25-17) yrs. The number of girls as the age increased (groups II and III). The mean headache attacks rate was 2.5 ± 1.5 per wk, which resulted in worsening of school performance (n = 26, 34.2%). In the majority of patients (n = 54, 71.1%), there was a family history of migraine or headache in the close relatives. Prophylaxis was found effective for all given medications (flunarizine: 46/54, propranolol: 19/21, topiramate: 10/10, sodium valproate: 1/1).
CONCLUSIONS: These findings indicate that: (a) migraine is the most frequent cause of headache in pediatric patients, (b) it has negative effects on school performance and daily activities, (c) the family history is important for making the diagnosis and (d) prophylaxis is significantly effective.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20886317     DOI: 10.1007/s12098-010-0210-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  21 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 2.  Headaches in the pediatric population.

Authors:  Paula M Brna; Joseph M Dooley
Journal:  Semin Pediatr Neurol       Date:  2006-12       Impact factor: 1.636

3.  Some clinical features of the acute migraine attack. An analysis of 750 patients.

Authors:  J Olesen
Journal:  Headache       Date:  1978-11       Impact factor: 5.887

Review 4.  [Prophylactic treatments of migraine].

Authors:  H Massiou
Journal:  Rev Neurol (Paris)       Date:  2000       Impact factor: 2.607

Review 5.  Clinical neurophysiology in childhood headache.

Authors:  F Puca; M de Tommaso
Journal:  Cephalalgia       Date:  1999-04       Impact factor: 6.292

6.  Natural history of migraine in childhood.

Authors:  M A Hernandez-Latorre; M Roig
Journal:  Cephalalgia       Date:  2000-07       Impact factor: 6.292

Review 7.  Migraine and women. The link between headache and hormones.

Authors:  S D Silberstein
Journal:  Postgrad Med       Date:  1995-04       Impact factor: 3.840

Review 8.  Epidemiology and diagnosis of migraine in children.

Authors:  Paul Winner; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2007-10

9.  Prevalence of headache at preschool age in an unselected child population.

Authors:  M Sillanpää; P Piekkala; P Kero
Journal:  Cephalalgia       Date:  1991-11       Impact factor: 6.292

10.  Validity of family history data on severe headache and migraine.

Authors:  R Ottman; S Hong; R B Lipton
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

View more
  4 in total

Review 1.  Preventive drugs in childhood and adolescent migraine.

Authors:  Joanne Kacperski; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2014-06

2.  Topiramate and propranolol for prophylaxis of migraine.

Authors:  Razieh Fallah; Mohammad Saleh Divanizadeh; Mehran Karimi; Mehrdad Mirouliaei; Ali Shamszadeh
Journal:  Indian J Pediatr       Date:  2013-02-15       Impact factor: 1.967

Review 3.  Prophylaxis of migraine in children and adolescents.

Authors:  Joanne Kacperski
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

4.  The efficacy and safety of topiramate for prophylaxis of migraine in children.

Authors:  Razieh Fallah; Sedighah Akhavan Karbasi; Ahmad Shajari; Mostafa Fromandi
Journal:  Iran J Child Neurol       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.